Squarepoint Ops LLC Amgen Inc Put Options Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $928,140 - $1.01 Million	-3,000 Reduced 11.76%	22,500 $7.25 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $5.41 Million - $6.58 Million	20,600 Added 420.41%	25,500 $7.97 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $8.42 Million - $10.2 Million	-31,300 Reduced 86.46%	4,900 $1.39 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $6.72 Million - $7.59 Million	26,300 Added 265.66%	36,200 $10.4 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $1.86 Million - $2.2 Million	-8,700 Reduced 46.77%	9,900 $2.2 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $2.01 Million - $2.45 Million	8,900 Added 91.75%	18,600 $4.5 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.22 Million - $2.82 Million	9,700 New	9,700 $2.55 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $8.21 Million - $9.14 Million	-35,600 Reduced 59.23%	24,500 $5.96 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $6.6 Million - $7.3 Million	30,100 Added 100.33%	60,100 $14.5 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $19,888 - $22,760	100 Added 0.33%	30,000 $6.75 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $2.57 Million - $3.01 Million	12,100 Added 67.98%	29,900 $6.36 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $12.1 Million - $13.4 Million	-51,600 Reduced 74.35%	17,800 $4.34 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $15.2 Million - $17.7 Million	68,600 Added 8575.0%	69,400 $17.3 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $187,720 - $208,760	-800 Reduced 50.0%	800 $203,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $278,576 - $333,792	1,600 New	1,600 $310,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account